Please login to the form below

Not currently logged in
Email:
Password:

Dr Reddy's makes senior changes as US generics head exits

UmangVohra will be replaced by Alok Sonig

Dr Reddy's Umang VohraDr Reddy's has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured).

Vohra is leaving the Indian generics-focused company after nearly three years as its executive VP and head North America Generics.

In total he spent 13 years with the firm, which he joined in 2002 from Pepsico-India, where he was financial planning manager.

Vohra's replacement at Dr Reddy's is the company's head of India generics Alok Sonig who, prior to joining the firm, served at Bristol-Myers Squibb, where he spent three years as managing director of BMS India.

To fill Sonig's vacant role Dr Reddy's has handed MV Ramana, currently executive vice president - emerging markets, additional responsibilities with a move to executive vice president and head branded markets (India and emerging countries).

1st September 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...